Screening for improved catalytic efficiency in cytochrome P450 variants reveals enhanced steroid hydroxylation mechanisms.
Cytochrome P450 CYP109B4 is a characterized 16β-steroid hydroxylase with significant potential in steroid drug biosynthesis, but its application is limited by reliance on costly coenzymes and complex electron transfer processes. To address this, we constructed a hydrogen peroxide (H₂O₂)-driven catalytic system through structure-guided engineering. Screening a combinatorial variant library identified the L240V/S387F double mutant, which exhibited emergent peroxygenase activity (baseline TTN = 11). Using focused rational iterative site-specific mutagenesis (FRISM), we obtained optimized variant B4-Pm9 exhibiting a 4-fold higher total turnover number (TTN = 44). Coupling with an alcohol dehydrogenase (Aldo)-based H₂O₂ regeneration system further enhanced catalytic efficiency, achieving a TTN of 348 (31-fold improvement over L240V/S387F mutant). Computational studies revealed the H₂O₂ activation mechanism in Pm7 and Pm9. Notably, variant B4-Pm7 demonstrated a novel mechanism of H₂O₂ cleavage mediated by the "alcohol-hydroxyl" moiety, showcasing a significant breakthrough in the realm of P450 peroxygenase.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: